Skip to the page

Data / Crowdfunding / Texas / Cizzle Bio, Inc.

Cizzle Bio, Inc.: crowdfunding raise on DEALMAKER SECURITIES LLC, $10,000 to $4,999,999 (2025)

Cizzle Bio, Inc., a corporation in San Antonio, TX, filed a Form C with the SEC on April 17, 2025 to raise $10,000 to $4,999,999 in Class B Non-Voting Common Stock through DEALMAKER SECURITIES LLC. The offering closed on April 15, 2026. In its most recent fiscal year it reported $0 in revenue and a net loss of $1,909,353.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
cizzlebio.com
Funding portal
DEALMAKER SECURITIES LLC
Address
2040 BABCOCK ROAD SUITE 201, San Antonio, TX 78229
Legal form
Corporation
Jurisdiction
TX
Incorporated
February 23, 2024
SEC CIK
0002043459

Offering terms

From the amendment filed April 17, 2025.

Security
Class B Non-Voting Common Stock
Price
$0.38
Target
$10,000
Maximum
$4,999,999
Deadline
April 15, 2026
Portal compensation
As compensation for the services provided by DealMaker Securities LLC, the Issuer shall pay to DealMaker Securities LLC a fee consisting of an eight and one-half percent (8.5%) cash commission.

Financials

From the Form C-U filed September 19, 2025.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$-1,909,353$0sec.gov
Taxes paid$0$0sec.gov
Total assets$693,948$0sec.gov
Cash$619,944$0sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$140,660$0sec.gov
Long-term debt$2,461,875$0sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
September 19, 2025Progress update$10,000$4,999,999April 15, 2026The Company closed the Offering and total proceeds raised during the Offering period were $14,650.42.sec.gov
April 17, 2025Amendment$10,000$4,999,999April 15, 2026This material amendment is filed to, among other things, (i) extend the Offering deadline to April 15, 2026; (ii) reduce the Minimum Individual Purchase Amount; (iii) update the Perks; and (iv) provide 2024 audited financials for the Issuer and Co-Issuer.sec.gov
April 17, 2025Amendment$10,000$4,999,999April 20, 2025This non-material amendment is filed to (i) extend the Perks deadline to March 31, 2025; and (ii) update the Capitalization and Ownership, Financial Information and Previous Offerings sections.sec.gov
February 3, 2025Amendment$10,000$4,999,999April 20, 2025This non-material amendment is filed to (i) extend the Perks deadline to March 31, 2025; and (ii) update the Capitalization and Ownership, Financial Information and Previous Offerings sections.sec.gov
November 4, 2024Amendment$10,000$4,999,999April 20, 2025This amendment is filed to correct a typographical error in the Deadline to reach the Target Offering Amountsec.gov
November 4, 2024Offering$10,000$4,999,999April 20, 2025sec.gov

All filings on sec.gov

Updated September 19, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.